Objective To compare the efficacy of covid-19 vaccines between immunocompromised and
immunocompetent people. Design Systematic review and meta-analysis. Data sources …

The coronavirus infectious disease (COVID-19) shows a remarkable symptomatic
heterogeneity. Several risk factors including advanced age, previous illnesses, and a …

Vaccines against SARS-CoV-2 have shown remarkable efficacy and thus constitute an
important preventive option against coronavirus disease 2019 (COVID-19), especially in …

The objectives of this study were to assess the immunogenicity and safety of COVID-19
vaccines in patients with hematologic malignancies. A systematic review and meta-analysis …

Purpose People living with cancer and haematological malignancies are at an increased
risk of hospitalisation and death following infection with acute respiratory syndrome …

Introduction Coronavirus disease 2019 resulted in a 30% mortality rate in patients with
thoracic cancer. Given that patients with cancer were excluded from serum antisevere acute …

Immunocompromised patients are considered high-risk and prioritized for vaccination
against COVID-19. We aimed to analyze B-cell subsets in these patients to identify potential …

Transmission of the SARS-CoV-2 virus and its corresponding disease (COVID-19) has been
shown to impose a higher burden on cancer patients than on the general population …

Background Cancer patients particularly those with hematological malignancies are at
higher risk of affecting by severe coronavirus disease 2019 (COVID-19). Due to the …

Background Immunocompromised (IC) patients are at higher risk of more severe COVID-19
infections than the general population. Special considerations should be dedicated to such …